After reporting Q1 earnings on May 5, shares of Palantir Technologies (NASDAQ:PLTR) sold-off despite beating Wall Street’s ...

Palantir's Q1 earnings failed to meet guidance expectations, driving selloff concerns. Find out if PLTR has more to rise or ...

Palantir Technologies (PLTR) kicked off 2025 with a blockbuster first quarter. This, in part, has helped PLTR stock rise 57% ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

Investing.com – U.S. stocks were mixed after the close on Monday, as gains in the Telecoms, Healthcare and Financials sectors led ...

Live Updates Live Coverage Has Ended Palantir May Have Another 18% of Upside 1:12 pm Using the high-end of analyst price ...

Shares of Palantir Technologies ( PLTR 8.01%) are surging on Thursday. The artificial intelligence (AI)-powered data ...

Palantir co-founder Joe Lonsdale believes Paul Tudor Jones' AI fears are exaggerated, but acknowledges its potential impact.

Palantir's artificial intelligence platform (AIP) continues to be its primary growth driver, particularly with U.S. commercial customers. The company credited AIP's ontology, or the operational layer ...

Incorporated 2006 and headquartered in Caesarea, Israel, IceCure Medical Ltd is a commercial stage medical device company that researches, develops and sells cryoablation devices for the freezing ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.